JMP Securities
http://www.jmpsecurities.com/index.htmlJMP Securities provides investment banking services, institutional brokerage, and equity research to public and private growth companies. Equity research is the backbone of the firm and the industries the firm covers are: Business Services, Financial Services, Real Estate, Consumer, Healthcare, and Technology. The firm is headquartered in San Francisco, CA and is a subsidiary of JMP Group (NYSE: JMP).
View Older Stories View More Recent Stories
-
Halozyme Therapeutics' (HALO) Price Target Raised to $21 at JMP
-
NephroGenex to Participate in Two Healthcare Conferences in June
-
Pre-Open Stock Movers 06/03: (SNCR) (GIII) (ESPR) Higher; (VMEM) (CDTI) (GEVO) Lower (more...)
-
Esperion Therapeutics (ESPR) PT Raised Sharply at JMP Securities on Upcoming Catalysts
-
JMP Securities Starts HTG Molecular Diagnostics (HTGM) at Market Outperform
-
Nevro (NVRO) Prices Larger 4.7M Common Stock Offering at $51/Share
-
Revionics Teams Up with Roundy’s Supermarkets & Price Revolution to Host a Panel Session at FMI Connect 2015
-
Nevro Announces Pricing of Upsized Public Offering of Common Stock
-
Globus Medical to Participate at Investor Events in June
-
AtriCure to Present at the JMP Securities Life Sciences Conference
-
Aratana Therapeutics to Participate in Two Upcoming Investor Conferences
-
CounterTack Announces $15M Series C Round of Financing
-
JMP Securities Starts William Lyon Homes (WLH) at Market Outperform
-
Foundation Medicine to Present at Upcoming Investor Conferences
-
Revionics and Price Revolution Partner to Deliver Industry-Leading Pricing Solutions
-
TubeMogul Files Registration Statement for Proposed Follow-On Offering
-
TubeMogul Files Registration Statement for Proposed Follow-On Offering
-
Nevro (NVRO) Commences Common Stock Offering
-
Nevro Announces Proposed Public Offering of Common Stock
-
Tobira Therapeutics to Present at Upcoming Investor and Scientific Conferences in June 2015
-
Haemonetics to Present at the JMP Securities Life Sciences Conference
-
JMP Securities Downgrades Marriott Vacations Worldwide (VAC) to Market Perform
-
JMP Securities Starts Enova International (ENVA) at Market Outperform
-
OncoMed to Present at Upcoming Investment Conferences
-
Alnylam to Webcast Presentations at Upcoming June Investor Conferences
-
Minerva Neurosciences to Present at Upcoming Investor Conferences in June
-
Raptor Pharmaceutical to Participate in Upcoming Investor Conferences
-
Raptor Pharmaceutical to Participate in Upcoming Investor Conferences
-
MannKind to Present at Upcoming Conferences
-
JMP Group Announces Addition of Randy Billhardt to Equity Capital Markets Division
-
Idera to Present at Two June Investor Healthcare Conferences
-
Infinity to Participate in Three Investor Conferences in June
-
Acceleron Pharma to Present at Upcoming Investor Conferences in June
-
Aerie Pharmaceuticals to Participate in Two Investor Conferences in June
-
Conatus to Present at Upcoming Investor Conferences
-
Concert Pharmaceuticals to Present at Two Upcoming Investor Conferences
-
Capricor Therapeutics to Participate in Two Upcoming Investor Conferences in June
-
Depomed To Present At Healthcare Conferences In June
-
Heron Therapeutics to Present at Investor Conferences in June 2015
-
JMP Securities Starts Blueprint Medicines (BPMC) at Market Outperform
-
JMP Securities Starts Expedia (EXPE) at Market Outperform
-
Egalet to Present at Upcoming Conferences in June
-
AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences In June
-
Horizon Pharma plc to Participate in Two Conferences in June
-
Meijer Acquires Aureus Health Services
-
Auris Medical Holding (EARS) Closes 5.28M Common Offering at $4.75/Share
-
Auris Medical Holding AG Announces Closing of Public Offering of Common Shares
-
Auris Medical Holding AG Announces Closing of Public Offering of Common Shares
-
JMP Securities Downgrades Achillion Pharmaceuticals (ACHN) to Market Perform
-
Revionics, The Parker Avery Group and RIS News to Host Webinar About Strategies for Omni-Channel Pricing

